Clinical Pharmacokinetics

Acknowledgement
pp. 981-983(3)
Author: Adis International Limited,

Antiarrhythmics: Elimination and Dosage Considerations in Hepatic Impairment
pp. 985-996(12)
Author: Klotz, Ulrich

Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy
pp. 997-1038(42)
Authors: Pea, Federico; Viale, Pierluigi; Pavan, Federica; Furlanut, Mario

Role of P-Glycoprotein Inhibition for Drug Interactions: Evidence from In Vitro and Pharmacoepidemiological Studies
pp. 1039-1049(11)
Authors: Eberl, Sonja; Renner, Bertold; Neubert, Antje; Reisig, Mareike; Bachmakov, Iouri; König, Jörg; Dörje, Frank; Mürdter, Thomas E.; Ackermann, Andreas; Dormann, Harald; Gassmann, Karl G.; Hahn, Eckhart G.; Zierhut, Stefanie; Brune, Kay; Fromm, Martin F.

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients: A Study by the EORTC-PAMM-NDDG
pp. 1051-1068(18)
Authors: Joerger, Markus; Huitema, Alwin D.R.; Richel, Dick J.; Dittrich, Christian; Pavlidis, Nikolas; Briasoulis, Evangelos; Vermorken, Jan B.; Strocchi, Elena; Martoni, Andrea; Sorio, Roberto; Sleeboom, Henk P.; Izquierdo, Miguel A.; Jodrell, Duncan I.; Féty, Régine; Ernst de Bruijn,; Hempel, Georg; Karlsson, Mats; Tranchand, Brigitte; Schrijvers, Ad H.G.J.; Twelves, Chris; Beijnen, Jos H.; Schellens, Jan H.M.